NervGen Pharma Corp. (TSXV:NGEN)
Canada flag Canada · Delayed Price · Currency is CAD
2.980
+0.010 (0.34%)
Apr 29, 2025, 12:17 PM EDT

NervGen Pharma Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
2112211619412478
Upgrade
Market Cap Growth
37.18%37.18%71.42%-24.19%58.14%36.12%
Upgrade
Enterprise Value
1942001466611671
Upgrade
Last Close Price
2.973.142.701.602.732.23
Upgrade
PB Ratio
81.8385.68-80.106.987.3613.23
Upgrade
P/TBV Ratio
99.84104.55-7.217.5814.37
Upgrade
Debt / Equity Ratio
0.040.04-0.100.02--
Upgrade
Quick Ratio
1.051.050.792.2015.767.50
Upgrade
Current Ratio
1.131.130.832.2716.168.21
Upgrade
Return on Equity (ROE)
-8460.20%-8460.20%-390.89%-136.87%-111.94%-190.21%
Upgrade
Return on Assets (ROA)
-95.24%-95.24%-59.88%-68.90%-65.17%-104.12%
Upgrade
Return on Capital (ROIC)
-3580.97%-3580.97%-186.22%-94.17%-70.43%-118.99%
Upgrade
Earnings Yield
-11.39%-10.87%-13.91%-22.07%-10.28%-14.28%
Upgrade
FCF Yield
--7.63%-7.02%-18.96%-6.68%-8.05%
Upgrade
Buyback Yield / Dilution
-13.55%-13.55%-12.61%-34.00%-22.35%-23.97%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.